AGM Details

The 33rd Annual General Meeting of Ishita Drugs and Industries Limited will be held on Wednesday, September 30, 2026 at 11:30 AM at "Manthan", Hotel Krsna Lila, Nr. Rexroth Bosch, Village Iyava, Taluka Sanand, Sanand Viramgam Highway, Gujarat 382170.

E-Voting Information

As per Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI(LODR) Regulation, 2015, the company is providing e-voting facility to members. The e-voting period commences on Sunday, September 27, 2026 (09:00 AM IST) and ends on Tuesday, September 29, 2026 (05:00 PM IST). The cut-off date for determining members eligible to vote is September 23, 2026.

Business to be Transacted

Ordinary Business:

1. To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026 together with the Reports of Board of Directors and Auditors thereon.

2. To consider the re-appointment of M/s Jaymin Shah & Associates, Chartered Accountants (FRN No. 129406W) as the Statutory Auditors of the Company for a period of one year from the conclusion of the 33rd AGM till the conclusion of the 34th AGM, on remuneration plus applicable taxes and out-of-pocket expenses as mutually agreed.

Special Business:

3. To approve re-appointment of Mrs. Abha Agrawal (DIN 01589479) as a Non-Executive Non-Independent Director of the Company post attaining the age of 75 years (Special Resolution required as per Regulation 17(1A) of SEBI LODR Regulations). Mrs. Abha Agrawal holds 250,796 shares (8.39%) as of March 31, 2026 and has attended 5 out of 5 board meetings during FY 2025-26.

4. To approve Related Party Transactions with Ishita Pharmaceuticals (Ordinary Resolution). Ishita Pharmaceuticals is engaged in manufacturing drugs, excipients and drug intermediates, with different product range from the company. Shri Jagdish Agrawal (Managing Director) and Shri Sumit Agrawal (CFO) are partners in Ishita Pharmaceuticals.

5. To approve Related Party Transactions with Anvi Lifesciences Private Limited (Ordinary Resolution). Anvi Lifesciences is engaged in manufacturing of finished dosage formulations and trading of APIs and drug intermediates. Shri Jagdish Agrawal is a member, while Smt. Abha Agrawal and Shri Sumit Agrawal are Directors and Members of ALPL.

Shareholder Information

The Register of Members and Share Transfer Books will remain closed from September 24, 2026 to September 30, 2026 (both days inclusive).

Additional Information

Meenu Maheshwari, Practicing Company Secretary of Meenu Maheshwari & Associates has been appointed as the Scrutinizer for the voting process. The company's Registrar and Share Transfer Agent is Bigshare Services Private Limited. Electronic copy of Annual Report 2025-26 is being sent to all members whose email IDs are registered with the RTA/Company.

Director Details - Mrs. Abha Agrawal

  • Date of Birth: February 12, 1951 (75 years)
  • Date of first appointment: February 5, 1992
  • Qualifications: M.A. (Psychology)
  • Experience: Promoter of the company with over 30 years of association, extensive business experience in chemicals and electrical switches & circuit breakers
  • Other Directorships: Ishita Overseas Private Limited, Anvi Lifesciences Private Limited
  • Committee Memberships: Nomination and Remuneration Committee (Member), Stakeholders Relationship Committee (Chairman)
  • Shareholding: 250,796 shares (8.39%) as of March 31, 2026
  • Relationship with other Directors: Spouse of Mr. Jagdish Agrawal, Managing Director

Transaction Details

The proposed related party transactions with Ishita Pharmaceuticals and Anvi Lifesciences Private Limited are expected to exceed 10% of the annual consolidated turnover of the company as per the last audited financial statements. All transactions are on arm's length basis and in the ordinary course of business, with tenure of up to 1 year. The transactions will be reviewed quarterly by the Audit Committee.